CC
RNAM

Centiva Capital’s Avidity Biosciences RNAM Stock Holding History

Centiva Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-55,000
Closed -$3.97M – 1962
2025
Q4 		$3.97M Buy
+55,000
New +$3.55M 0.03% 299

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Centiva Capital's RNAM Position: Q1 2026 in Review

Centiva Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 55,000 shares — an estimated $3.97M sold.

Centiva Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $3.97M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Centiva Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 55,000 Avidity Biosciences shares in Q1 2026, an estimated $3.97M.
  • Centiva Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Centiva Capital's Avidity Biosciences position peaked at $3.97M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.